Treatment-Resistant Depression
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Our ability to treat depression has improved with the availability of receptor-specific and chemically diverse groups of antidepressants. Even now, most of the short-term studies indicate that about 20% of depressed patients remain resistant to treatment. Therefore, it is important to properly assess the treatment-resistant depressed (TRD) patients and to separate the truly refractory patients from those inadequately treated. Undiagnosed medical conditions should be eliminated. TRD is neither a clinically nor a biologically identifiable entity. As there are no established methods for the treatment of TRD, all options should be considered. The clinician can be enriched by the knowledge of the treatment modalities available, and yet, in treating an individual patient, clinical skills, intuitive judgment, family history of response to drugs and side effects, all play a vital role. Several of the approaches described in the paper indicate available methods and their merits in general but there is no way of ascertaining by which particular method a patient should be treated. The three common methods of treatment are substitution of one antidepressant drug for another, combination therapies and augmentation techniques. These are based on clinical experiences and not research findings. Therefore the treatment of TRD patients is more an art than a science. The physician should assess all the psychopathological, phenomenological and psychosocial variables to appropriately treat an individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term Outcome of Episodes of Major Depression: Clinical and Public Health Significance
Keller, M. B. (1984) · JAMA · doi:10.1001/jama.252.6.788 · Cited by 295
Venlafaxine for Treatment-Resistant Unipolar Depression
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00008 · Cited by 198
The Concept of Recovery in Affective Disorders
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289025 · Cited by 113
Cognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder
Fava, G. A., Savron, G., Grandi, S., & Rafanelli, C. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0608b · Cited by 92
Monoamine oxidase inhibitors in resistant major depression
Nolen, W. A., Haffmans, P. M. J., Bouvy, P. F., & Duivenvoorden, H. J. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90104-r · Cited by 56 · cited 1×
“In a double-blind comparison of brofaromine with tranylcypromine in 39 depressed patients refractory to TCAs [”
Background
Cited by
Berlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
“Nonresponse in the absence of any side effect is a useful guide to raising the possibility of less than adequate antidepressant blood levels, and its measurement may be indicated in these circumstances.(1,6,7)”
BackgroundFava, G. A., & Ruini, C. (2003) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(03)00019-3 · Cited by 386
Well-being therapy: Conceptual and technical issues
Fava, G. A. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012329 · Cited by 311
The burden of severe depression: A review of diagnostic challenges and treatment alternatives
Nemeroff, C. B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.008 · Cited by 295
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
“Method of evaluation Although the systematic evaluation of previous courses of treatment is considered fundamental prior to any decision on the management of resistant/refractory cases (Ananth, 1998; Souery et al., 2001; Fava, 2003), the majority of the retrieved studies (n=37 or 79%) did not report the method employe…”
BackgroundMethodDefining Treatment-Resistant Depression: A Comprehensive Review of the Literature
Trevino, K., McClintock, S. M., Fischer, N. M., Vora, A., & Husain, M. M. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600310 · Cited by 130
“…requiring 2 failed antidepressant medications from different classes is generally accepted in the psychiatric literature as more representative of TRD. 7,24,35,46,54,58 Despite these added benefits, the European staging method does not address symptom severity or medication augmentation strategies.”
Nakao, M., & Yano, E. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.09.010 · Cited by 41
Potential Sensitising Effects of Antidepressant Drugs on Depression
Fava, G. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00001 · Cited by 23
Metadata
- Authors
- Ananth, J.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 67
- Issue
- 2
- Pages
- 61-70
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W1989627644
- Cited by
- 64
- References
- 5
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.